Search research articles
Contact Us
Filters
Showing results (51-60 of 92) with videos related to
Page
of 10
Sort By:
Acta Neurologica
|
July 1, 1976
[Changes in brain levels of taurine and glutamate induced by cortical perfusion with taurine]
L Durelli, M Mazzarino, M Delsedime, et al.
Neurology
|
March 4, 1998
Interferon treatment for multiple sclerosis: autoimmune complications may be lethal
L Durelli, M R Bongioanni, B Ferrero, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 1, 1975
Soradic ulcerative mutilating acropathy with imbalance of free amino acids in the cerebrospinal fluid
F Monaco, A Riccio, A Covacich, et al.
Neurology
|
November 1, 1993
Total body irradiation for myasthenia gravis: a long-term follow-up
L Durelli, M F Ferrio, A Urgesi, et al.
Journal of the Neurological Sciences
|
October 6, 2000
Does high-dose interferon beta-1b improve clinical response in more severely disabled multiple sclerosis patients?
L Durelli, A Oggero, E Verdun, et al.
Minerva Medica
|
June 16, 1983
[Hypokalemic myopathy caused by fluoroprednisolone in a nasal spray. Observations 2 cases]
R Cantello, L Bergamini, M Delsedime, et al.
Neurology
|
October 24, 2001
Liver and thyroid function and autoimmunity during interferon-beta 1b treatment for MS
L Durelli, B Ferrero, A Oggero, et al.
Brain Research
|
February 25, 1977
Longitudinal changes of brain amino acid content occurring before, during and after epileptic activity
R Mutani, L Durelli, M Mazzarino, et al.
Clinical Chemistry
|
May 1, 1997
Modified and improved anti-acetylcholine receptor (AchR) antibody assay: comparison of analytical and clinical performance with conventional anti-AChR antibody assay
B Ferrero, G Aimo, R Pagni, et al.
Annals of the New York Academy of Sciences
|
June 21, 1993
Therapies for exacerbation of myasthenia gravis. The mechanism of action of intravenous high-dose immunoglobulin G
B Ferrero, L Durelli, R Cavallo, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 92) with videos related to
Sort By:
Page
of 10
Acta Neurologica
|
July 1, 1976
[Changes in brain levels of taurine and glutamate induced by cortical perfusion with taurine]
L Durelli, M Mazzarino, M Delsedime, et al.
Neurology
|
March 4, 1998
Interferon treatment for multiple sclerosis: autoimmune complications may be lethal
L Durelli, M R Bongioanni, B Ferrero, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 1, 1975
Soradic ulcerative mutilating acropathy with imbalance of free amino acids in the cerebrospinal fluid
F Monaco, A Riccio, A Covacich, et al.
Neurology
|
November 1, 1993
Total body irradiation for myasthenia gravis: a long-term follow-up
L Durelli, M F Ferrio, A Urgesi, et al.
Journal of the Neurological Sciences
|
October 6, 2000
Does high-dose interferon beta-1b improve clinical response in more severely disabled multiple sclerosis patients?
L Durelli, A Oggero, E Verdun, et al.
Minerva Medica
|
June 16, 1983
[Hypokalemic myopathy caused by fluoroprednisolone in a nasal spray. Observations 2 cases]
R Cantello, L Bergamini, M Delsedime, et al.
Neurology
|
October 24, 2001
Liver and thyroid function and autoimmunity during interferon-beta 1b treatment for MS
L Durelli, B Ferrero, A Oggero, et al.
Brain Research
|
February 25, 1977
Longitudinal changes of brain amino acid content occurring before, during and after epileptic activity
R Mutani, L Durelli, M Mazzarino, et al.
Clinical Chemistry
|
May 1, 1997
Modified and improved anti-acetylcholine receptor (AchR) antibody assay: comparison of analytical and clinical performance with conventional anti-AChR antibody assay
B Ferrero, G Aimo, R Pagni, et al.
Annals of the New York Academy of Sciences
|
June 21, 1993
Therapies for exacerbation of myasthenia gravis. The mechanism of action of intravenous high-dose immunoglobulin G
B Ferrero, L Durelli, R Cavallo, et al.
Page
of 10